Wyeth Biopharma competitors

Zippia score 4.7

Wyeth Biopharma main competitors are AstraZeneca, Novartis, and Boehringer Ingelheim.

Competitor Summary. See how Wyeth Biopharma compares to its main competitors:

Novartis has the most employees (110,000).
Employees at AstraZeneca earn more than most of the competitors, with an average yearly salary of $112,988.
The oldest company is Mallinckrodt, founded in 1867.

Work at Wyeth Biopharma?

Share your experience

Wyeth Biopharma vs competitors

Company	Founding date	Zippia score	Headquarters	# of Locations	Revenue	Employees
Wyeth Biopharma	1860	4.7	Madison, NJ	1	$22.4B	49,732
Allergan plc	1948	4.8	Irvine, CA	1	$7.2B	11,400
Boehringer Ingelheim	1984	4.6	Ridgefield, CT	5	$17.2B	52,391
Watson Pharma Pvt Ltd	1984	4.9	Parsippany-Troy Hills, NJ	1	$5.9B	21,600
Alpharma	1975	4.4	Madison, NJ	1	$350.0M	2,000
Mylan	1961	4.8	Canonsburg, PA	2	$11.5B	35,000
Novartis	1996	4.9	East Hanover, NJ	16	$51.7B	110,000
Roche Holding AG	1987	4.7	South San Francisco, CA	1	$61.0B	94,442
Forest Laboratories	1954	4.8	New York, NY	1	$3.6B	6,200
SmithKline Beecham Holdings Corporation	1996	4.3	Wilmington, DE	1	-	1,500
Roche Diagnostics Middle East	2012	4.5	-	-	$53.0M	635
Janssen	1953	4.9	Raritan, NJ	4	$601.4M	1,500
AstraZeneca	1999	4.6	Wilmington, DE	8	$25.9B	76,100
Sun Pharmaceutical Industries Inc.	1984	4.6	Cranbury, NJ	3	$4.2B	32,000
Noven	1987	4.6	Miami, FL	2	$520.0M	586
Aptuit	2004	4.3	Greenwich, CT	1	$100.0M	1,733
Mallinckrodt	1867	4.8	Hazelwood, MO	5	$1.0B	3,400
Merial Limited	1981	4.8	Duluth, GA	1	$2.7B	6,900
Zoetis	1952	4.9	Parsippany-Troy Hills, NJ	6	$9.3B	11,300
Sigma-Aldrich	1951	4.9	Saint Louis, MO	2	$2.8B	9,600
Paddock Laboratories	1977	4.3	Minneapolis, MN	1	$100.5M	51

Rate how well Wyeth Biopharma differentiates itself from its competitors.

Wyeth Biopharma salaries vs competitors

Among Wyeth Biopharma competitors, employees at AstraZeneca earn the most with an average yearly salary of $112,988.

Compare Wyeth Biopharma salaries vs competitors

Company	Average salary	Hourly salary	Salary score
Wyeth Biopharma	$77,257	$37.14	-
Allergan plc	$99,508	$47.84	-
Boehringer Ingelheim	$106,981	$51.43	-
Watson Pharma Pvt Ltd	$79,372	$38.16	-
Alpharma	$61,984	$29.80	-
Mylan	$66,113	$31.79	-

Compare Wyeth Biopharma job title salaries vs competitors

Company	Highest salary	Hourly salary
Wyeth Biopharma	$71,285	$34.27
Merial Limited	$85,417	$41.07
Novartis	$81,909	$39.38
Watson Pharma Pvt Ltd	$81,344	$39.11
AstraZeneca	$80,478	$38.69
Boehringer Ingelheim	$78,636	$37.81
Janssen	$78,593	$37.79
Allergan plc	$78,280	$37.63
Forest Laboratories	$76,932	$36.99
Sigma-Aldrich	$76,024	$36.55
Zoetis	$75,252	$36.18
Roche Diagnostics Middle East	$75,006	$36.06
Paddock Laboratories	$66,549	$31.99
Sun Pharmaceutical Industries Inc.	$65,867	$31.67
Roche Holding AG	$65,755	$31.61
Aptuit	$62,652	$30.12
Mylan	$61,793	$29.71
SmithKline Beecham Holdings Corporation	$61,568	$29.60
Noven	$61,532	$29.58
Alpharma	$61,338	$29.49

Do you work at Wyeth Biopharma?

Does Wyeth Biopharma effectively differentiate itself from competitors?

Wyeth Biopharma jobs

Wyeth Biopharma demographics vs competitors

Compare gender at Wyeth Biopharma vs competitors

Job title	Male	Female
AstraZeneca	52%	48%
Novartis	54%	46%
Roche Holding AG	56%	44%
Mylan	57%	43%
Sun Pharmaceutical Industries Inc.	62%	38%
Wyeth Biopharma	-	-

Male

Female

100%

75%

50%

25%

Wyeth Biopharma

Sun Pharmaceutical Industries Inc.

25%

50%

75%

100%

Compare race at Wyeth Biopharma vs competitors

Company	White	Hispanic or Latino	Black or African American	Asian	Unknown	Diversity score
AstraZeneca	60%	13%	11%	12%	4%	9.8
Mylan	62%	18%	7%	10%	3%	9.3
Novartis	55%	15%	10%	15%	4%	9.9
Roche Holding AG	57%	17%	10%	12%	4%	9.8
Sun Pharmaceutical Industries Inc.	43%	10%	9%	32%	6%	9.8
Allergan plc	52%	19%	10%	15%	5%	9.9

Wyeth Biopharma and similar companies CEOs

CEOBio

Juan Ramón Alaix

Zoetis

Juan Ramón Alaix was appointed chief executive officer of Zoetis in July 2012. In this role, he leads the world’s largest company with a singular focus on animal health medicines and vaccines. He is a member of the Zoetis Board of Directors. Mr. Alaix served as President of Pfizer Animal Health since 2006, where he was responsible for the overall strategic direction and financial performance of the company. Under his leadership, the company generated annual revenue of $4.8 billion in 2015 with approximately 9,000 employees worldwide. Zoetis serves veterinarians, livestock producers and people who raise and care for farm and companion animals with sales of its products in more than 100 countries. He joined Pfizer from Pharmacia in 2003 as Regional President. He has 35 years’ experience of increasing responsibility in finance, commercial and management, including 20 years in the pharmaceutical industry. In the 1990s, Mr. Alaix served in general management with Rhône-Poulenc Rorer in Spain and Belgium before becoming country President of Spain for Pharmacia in 1998. In 2013, Mr. Alaix completed a two-year term as President of the International Federation for Animal Health (IFAH), now known as HealthforAnimals, in addition to serving as a member of the board and executive committee. HealthforAnimals represents manufacturers of veterinary medicines, vaccines and other animal health products in both developed and emerging markets. Mr. Alaix continues to serve as a member of the HealthforAnimals board and executive committee. A native of Spain, Mr. Alaix received a graduate degree in economics from the Universidad de Madrid.

Kristin Peck

Alpharma

Satya Chava

Aptuit

Satya Chava is a Chief Executive Officer at Aptuit and is based in Greenwich, CT area.

Pascal Soriot

Mark Trudeau

Carsten Hellmann

Heather Bresch

Heather Manchin Bresch (Manchin; born June 27, 1969) is an American business executive. In 2012, she was named as the chief executive officer (CEO) of Netherlands-based pharmaceutical company Mylan, becoming the first woman to run a Fortune 500 pharmaceutical company. Bresch retired in 2020, upon the closing of Mylan’s combination with Upjohn. In 2015, she was listed as #22 in Fortune magazine's “Most Powerful Women” list.

Vasant Narasimhan

Novartis

Vasant "Vas" Narasimhan is an American physician and the chief executive officer of Novartis (since 2018).

Severin Schwan

Roche Holding AG

Abhay Gandhi

Sun Pharmaceutical Industries Inc.